Pfizer's stock is poised for recovery, driven by recent corporate news and a three-year reprieve on drug-import tariffs from the Trump administration, strengthening the bullish case despite prior ...

Pfizer Inc. has re-entered the obesity drug sector by acquiring Metsera, Inc., having successfully outmaneuvered six other bidders. Despite skepticism over Pfizer's recent acquisitions, Metsera's ...

This is read by an automated voice. Please report any issues or inconsistencies here. President Trump’s deal with Pfizer on drug prices won’t do much for American patients, but it’s great for Pfizer.

WASHINGTON — President Donald Trump and drug manufacturer Pfizer announced a deal Tuesday to lower certain drug prices. The arrangement would bring American drug prices in line with the lowest paid by ...

Proponents of Health and Human Services Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” (MAHA) agenda are outraged over the Trump administration’s deal with pharmaceutical giant Pfizer, ...

After its best day in nearly four years Tuesday, Pfizer stock gave an encore performance. Shares of the drugmaker closed up 6.8% as investors digested Tuesday's news that Pfizer would get a three-year ...

Listen to more stories on the Noa app. Sign up for Trump’s Return, a newsletter featuring coverage of the second Trump presidency. Donald Trump, always one to tout his knack for dealmaking, declared ...

"Today, I'm thrilled to announce that one of the world's largest pharmaceutical manufacturers and one of the best anywhere in the world, Pfizer, has agreed to offer countless prescription medications ...

Shares of Pfizer Inc. (NYSE:PFE) continue to head higher on Wednesday, a day after the company announced that it has secured a three-year grace period from President Donald Trump's tariffs on ...

A deal between Pfizer and former President Donald Trump is sending shockwaves through both the healthcare industry and Washington — and not everyone saw it coming. Pfizer, one of the largest ...

Washington — Pfizer has agreed to offer significantly discounted prices for some prescription drugs for all American consumers and has committed to offer prescription medications to Medicaid at lower ...

The White House announced a new direct-to-consumer drug sale website called TrumpRx, which Pfizer will participate in with drug discounts. The TrumpRx website is expected to launch by early 2026.